ACH’s statement was included in Bloomberg Law’s article today on HRSA’s letter to J&J on their proposed 340 drug rebate program: HRSA wrote it expects J&J to cease implementation immediately and to inform the agency no later than Sept. 30 in order to provide adequate notice to covered entities. Hospital groups including 340B Health and Advocates […]